Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cytokinetics
(NQ:
CYTK
)
57.32
+1.07 (+1.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cytokinetics
< Previous
1
2
3
4
5
6
7
Next >
Unpacking the Latest Options Trading Trends in Cytokinetics
February 28, 2024
Via
Benzinga
Here's How Much $1000 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
February 27, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Overbought, Overextended - What's The Buzz In S&P 500 Now?
February 14, 2024
Here are the red flags you need to be aware of in this current market and the directional bias for the long-term, swing and immediate term.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
February 09, 2024
Via
Benzinga
3 Biotech Stocks to Buy for the Next Bull Run: February 2024
February 08, 2024
These are the biotech stocks to buy that you must have on your watchlist for the coming bull run. It could get started as soon as this month.
Via
InvestorPlace
Here's How Much $100 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
February 02, 2024
Via
Benzinga
2 Biotechs That Could Get Bought Out in 2024
January 03, 2024
These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason.
Via
The Motley Fool
How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month
February 08, 2024
Cytokinetics is looking to take on Bristol Myers Squibb in treating a heart disease.
Via
Investor's Business Daily
Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session
February 05, 2024
U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Monday. Shares of Banco Santander, S.A. (NYSE: SAN) shares fell sharply during today’s pre-market trading.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
January 26, 2024
Investors should consider picking up these healthcare stocks at 52-week lows to benefit from their potential rebound.
Via
InvestorPlace
Biotech Playbook: Small Caps Show Momentum Peaking During
January 15, 2024
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
January 15, 2024
Via
Benzinga
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
January 12, 2024
Novartis halts pursuit of Cytokinetics acquisition, impacting promising heart drug. Analysts estimate $3.6 billion sales for Cytokinetics' cardiomyopathy drug by 2032. Still lead drug aficamten viewed...
Via
Benzinga
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
January 11, 2024
Novartis AG (NYSE: NVS) has decided to step back from pursuing the Cytokinetics Inc (NASDAQ: CYTK) acquisition, dealing a blow to the potential deal with the
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 11, 2024
Via
Benzinga
Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday
January 11, 2024
U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSE: ASPN) fell sharply during Thursday’s session after the company issued a...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bullish Continuation In '24? 3 Market Areas To Watch
January 10, 2024
This article discusses 3 market areas that should outperform dramatically over the next 12 months...
Via
Talk Markets
What's Been Happening With Cytokinetics Stock?
January 09, 2024
Cytokinetics, Incorporated (NASDAQ: CYTK) shares are trading lower on Tuesday, pulling back from Monday strength.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 09, 2024
Via
Benzinga
Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today?
January 08, 2024
Cytokinetics Inc (NASDAQ: CYTK) shares are trading higher after a report on potential takeover talks with Novartis AG (NYSE: NVS).
Via
Benzinga
Cytokinetics Rockets 14% As Novartis Reportedly Nears A Buyout Deal
January 08, 2024
The company is working on a treatment for a disease that can lead to heart failure.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 08, 2024
Via
Benzinga
CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
January 05, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2024
Via
Benzinga
7 Stocks Primed for a Spectacular Comeback in 2024
January 03, 2024
Although the usual suspects may carry confidence, these underappreciated comeback stocks might deliver the goods in 2024.
Via
InvestorPlace
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 29, 2023
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Via
Benzinga
Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study
December 28, 2023
On Thursday, Cytokinetics stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 99 from 89 the day before.
Via
Investor's Business Daily
Cytokinetics' Drug Potential: Analyst Suggests Key Role Of Established Pharma For Potential Launch
December 28, 2023
On Wednesday, Cytokinetics Incorporated (NASDAQ: CYTK) released topline results from the SEQUOIA-HCM Phase 3 trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy...
Via
Benzinga
Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday
December 28, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.